Akebia Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Milestones

Go back to Akebia Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Milestones
AKEBIA THERAPEUTICS (NASDAQ: AKBA) Delayed: 1.12 +0.03 (2.75%)
Previous Close $1.09    52 Week High $13.20 
Open $1.09    52 Week Low $7.00 
Day High $1.14    P/E N/A 
Day Low $1.09    EPS $0.00 
Volume 978,565